Literature DB >> 20002470

Evaluation of proposed oral disposition index measures in relation to the actual disposition index.

R Retnakaran1, Y Qi, M I Goran, J K Hamilton.   

Abstract

Aims While the disposition index provides a useful measure of B-cell function, its calculation requires the performance of a frequently sampled intravenous glucose tolerance test (FSIVGTT). Recently, the demonstration of a hyperbolic relationship between indices of insulin secretion and insulin sensitivity derived from the oral glucose tolerance test (OGTT) has led to the introduction of two novel OGTT-based measures of B-cell function analogous to the disposition index: (i) the insulin secretion-sensitivity index-2 (ISSI-2) (defined as the ratio of the area-under-the-insulin-curve to the area-under-the-glucose curve, multiplied by the Matsuda index) and (ii) insulinogenic index (IGI)/fasting insulin. However, neither of these two measures has been directly compared with the disposition index. Methods Two hundred and thirteen non-diabetic children (122 boys, 91 girls) underwent both OGTT and FSIVGTT, allowing for the calculation of ISSI-2, IGI/fasting insulin and the disposition index. Results ISS1-2 and IGI/fasting insulin were strongly correlated with each other (r = 0.82, P < 0.0001). Both measures correlated with the disposition index, with ISSI-2 showing a modestly stronger association (ISSI-2: r = 0.24, P = 0.0003; IGI/fasting insulin: r = 0.21, P = 0.0022). Standardized linear regression analyses confirmed that the relationship between log ISSI-2 and the disposition index (standardized regression coefficient = 0.224, P = 0.001) was stronger than that between log IGI/fasting insulin and the disposition index (standardized regression coefficient = 0.166, P = 0.015). Conclusions The OGTT-derived measures ISSI-2 and IGI/fasting insulin exhibit modest correlations with the disposition index. These relationships require further assessment in other patient populations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20002470     DOI: 10.1111/j.1464-5491.2009.02841.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  96 in total

1.  Impact of daily incremental change in environmental temperature on beta cell function and the risk of gestational diabetes in pregnant women.

Authors:  Ravi Retnakaran; Chang Ye; Caroline K Kramer; Anthony J Hanley; Philip W Connelly; Mathew Sermer; Bernard Zinman
Journal:  Diabetologia       Date:  2018-08-15       Impact factor: 10.122

2.  Association of NEFA composition with insulin sensitivity and beta cell function in the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort.

Authors:  Luke W Johnston; Stewart B Harris; Ravi Retnakaran; Adria Giacca; Zhen Liu; Richard P Bazinet; Anthony J Hanley
Journal:  Diabetologia       Date:  2017-12-24       Impact factor: 10.122

3.  Comparison of metabolic effects of surgical-induced massive weight loss in patients with long-term remission versus non-remission of type 2 diabetes.

Authors:  Fernanda Filgueira Hirsch; Jose Carlos Pareja; Sylka Rodovalho Geloneze; Elinton Chaim; Everton Cazzo; Bruno Geloneze
Journal:  Obes Surg       Date:  2012-06       Impact factor: 4.129

4.  Insulin secretion based on the late oral glucose tolerance test period and incident diabetes: the San Antonio Heart Study.

Authors:  C Lorenzo; K Williams; S M Haffner
Journal:  Diabet Med       Date:  2012-08       Impact factor: 4.359

5.  Elevated serum ceramides are linked with obesity-associated gut dysbiosis and impaired glucose metabolism.

Authors:  Brandon D Kayser; Edi Prifti; Marie Lhomme; Eugeni Belda; Maria-Carlota Dao; Judith Aron-Wisnewsky; Anatol Kontush; Jean-Daniel Zucker; Salwa W Rizkalla; Isabelle Dugail; Karine Clément
Journal:  Metabolomics       Date:  2019-10-11       Impact factor: 4.290

6.  Delayed timing of post-challenge peak blood glucose predicts declining beta cell function and worsening glucose tolerance over time: insight from the first year postpartum.

Authors:  Caroline K Kramer; Chang Ye; Anthony J G Hanley; Philip W Connelly; Mathew Sermer; Bernard Zinman; Ravi Retnakaran
Journal:  Diabetologia       Date:  2015-03-12       Impact factor: 10.122

Review 7.  Methods for Measuring Risk for Type 2 Diabetes in Youth: the Oral Glucose Tolerance Test (OGTT).

Authors:  Melinda E Chen; Rebecca S Aguirre; Tamara S Hannon
Journal:  Curr Diab Rep       Date:  2018-06-16       Impact factor: 4.810

8.  Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes.

Authors:  Sheena Kayaniyil; Reinhold Vieth; Ravi Retnakaran; Julia A Knight; Ying Qi; Hertzel C Gerstein; Bruce A Perkins; Stewart B Harris; Bernard Zinman; Anthony J Hanley
Journal:  Diabetes Care       Date:  2010-03-09       Impact factor: 19.112

9.  Beta-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy.

Authors:  Ravi Retnakaran; Ying Qi; Mathew Sermer; Philip W Connelly; Anthony J G Hanley; Bernard Zinman
Journal:  Diabetes Care       Date:  2010-05-18       Impact factor: 17.152

10.  Effects of genetic severity on glucose homeostasis in Friedreich ataxia.

Authors:  Charles J Isaacs; Karlla W Brigatti; Olena Kucheruk; Sarah Ratcliffe; Tom Sciascia; Shana E McCormack; Steven M Willi; David R Lynch
Journal:  Muscle Nerve       Date:  2016-08-30       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.